Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis
Clinical trial NCT00822315 · COMPLETED
Trial details
- NCT number
- NCT00822315
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2011-11-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.